NCCJ Clinical Research Seminar - DCT and GenAI
In this course, Dr. Kenichi Nakamura of the National Cancer Center Hospital, Japan, will explain two initiatives in clinical trials: decentralized clinical trials and the use of generative AI.
This is an excerpt from a seminar held on October 14, 2025, as part of the "Clinical Research Seminar" series held at the National Cancer Center Japan for staff involved (or expected to be involved) in clinical research, such as investigators and clinical research coordinators. Please note that the information contained in this content is current as of October 2025.
In this course, Dr. Kenichi Nakamura of the National Cancer Center Hospital, Japan, will explain two initiatives in clinical trials: decentralized clinical trials and the use of generative AI.
This is an excerpt from a seminar held on October 14, 2025, as part of the "Clinical Research Seminar" series held at the National Cancer Center Japan for staff involved (or expected to be involved) in clinical research, such as investigators and clinical research coordinators. Please note that the information contained in this content is current as of October 2025.
-
Decentralized Clinical Trials (DCT) and the Application of Generative AI in Clinical Trials
Decentralized Clinical Trials (DCT) and the Application of Generative AI in Clinical Trials
Years have passed since digital transformation began in clinical research. Advances in science and technology, as well as the discovery of new therapeutic agents and developments in statistical methods, have brought great benefits to patients and clinical research staff. But with these advances come new challenges for contemplation.This lecture will provide an overview of two new concepts introduced to clinical research in recent years: decentralized clinical trials and the application of generative AI.